In summary, our results firstly demonstrate that a fusion protein vaccine with CFA based on the M. tuberculosis protein Ag85B and 3×STEAP1186-193 induced a CTL response against prostate cancer cells and inhibited tumor growth in vivo. The gene discussed is PROS1; the disease is prostate carcinoma.